(Reuters) - The U.S. National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to COVID-19 vaccines made by Moderna Inc and Pfizer Inc. (Clinicaltrials.gov NCT04761822 https://bit.ly/3dG9JaK)
Reuters Health Information © 2021
processing....
Dear Nurses, Your COVID Vaccine Experience Matters
How Three Families Chose to Enroll Their Kids in COVID-19 Vaccine Trials
Next-Generation COVID Vaccines Have Many Different Targets
Half of US Adults Have at Least One COVID-19 Vaccine Shot
ACIP Provides Guidelines on Distribution of COVID-19 Vaccine
0.25 CME / CE / ABIM MOC Credits
How Three Families Chose to Enroll Their Kids in COVID-19 Vaccine Trials
Comments